Mode of action of biogenic silver, zinc, copper, titanium and cobalt nanoparticles against antibiotics resistant pathogens
The rapid surge in antibiotic resistance to pathogens has emerged as a grave threat to
public health, globally. This multiple drug resistance (MDR) is directly linked to the high rates …
public health, globally. This multiple drug resistance (MDR) is directly linked to the high rates …
Updates in pulmonary drug‐resistant tuberculosis pharmacotherapy: A focus on BPaL and BPaLM
Drug‐resistant tuberculosis (TB) is a major public health concern and contributes to high
morbidity and mortality. New evidence supports the use of shorter duration, all‐oral …
morbidity and mortality. New evidence supports the use of shorter duration, all‐oral …
[HTML][HTML] Improving quality of patient data for treatment of multidrug-or rifampin-resistant tuberculosis
JR Campbell, D Falzon, F Mirzayev… - Emerging Infectious …, 2020 - ncbi.nlm.nih.gov
International policy for treatment of multidrug-and rifampin-resistant tuberculosis (MDR/RR
TB) relies largely on individual patient data (IPD) from observational studies of patients …
TB) relies largely on individual patient data (IPD) from observational studies of patients …
莫西沙星联合用药方案对耐多药肺结核患者血清游离氨基酸和免疫功能的影响.
顾小燕， 胡春梅， 尹春阳， 方刚… - Progress in Modern …, 2020 - search.ebscohost.com
摘要目的: 探讨莫西沙星联合用药方案对耐多药肺结核(MDR-TB) 患者血清游离氨基酸和免疫
功能的影响. 方法: 选取2015 年9 月到2018 年1 月期间我院收治的90 例MDR-TB 患者 …
功能的影响. 方法: 选取2015 年9 月到2018 年1 月期间我院收治的90 例MDR-TB 患者 …
Estimating the effect of a rifampicin resistant tuberculosis diagnosis by the Xpert MTB/RIF assay on two-year mortality
Studies assessing patient-centred outcomes of novel rifampicin resistant tuberculosis (RR-
TB) diagnostics are rare and mostly apply conventional methods which may not adequately …
TB) diagnostics are rare and mostly apply conventional methods which may not adequately …
Reply to:" human rights: finding the right balance for rifampicin-resistant TB treatment".
V Cox, L Guglielmetti, C Hewison, A Reuter, J Furin - 2021 - cabidigitallibrary.org
The author agrees with the correspondence of Van Deun and colleagues regarding their
manuscript on all-oral, shorter regimens for the treatment of people living with rifampicin …
manuscript on all-oral, shorter regimens for the treatment of people living with rifampicin …